CD80+ and CD86+B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis
暂无分享,去创建一个
A. Vandamme | R. Liblau | D. Brassat | R. Khouri | E. Gotuzzo | C. Alvarez | R. Kruschewsky | S. M. Menezes | D. Decanine | S. V. Schnitman | M. Talledo | Giovanni López | J. V. Weyenbergh | Bernardo Galvão-Castro